The anti-malaria drug touted by U.S. President Donald Trump as a COVID-19 treatment was ineffective for patients with a mild version of the disease in a study conducted by researchers at the University of Minnesota.
FILE PHOTO: A pharmacist displays a box of Hydroxychloroquine at the CHR Centre Hospitalier Regional de la Citadelle Hospital amid the coronavirus disease in Liege, Belgium, June 16, 2020. REUTERS/Yves Herman
The randomized, placebo-controlled study was conducted on 491 non-hospitalized patients. Owing to test shortages in the United States, only 58% of participants were tested for the disease. The study “provides strong evidence that hydroxychloroquine offers no benefit in patients with mild illness,” Dr. Neil Schluger of New York Medical College said in an commentary on the study, also scheduled to be published on Thursday.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Hydroxychloroquine also doesn't help Covid-19 patients who aren't hospitalized, new study findsThe antimalarial drug hydroxychloroquine did not benefit non-hospitalized patients with mild Covid-19 symptoms who were treated early in their infection, according to a new study
Read more »
Another Study Finds Hydroxychloroquine Ineffective Against Covid-19—As Trump Continues To Hype ItOn June 15, the FDA revoked its emergency use authorization for the drug, following numerous studies that illustrated no benefits of its use with hospitalized patients.
Read more »
Another Study Finds Hydroxychloroquine Ineffective Against Covid-19—As Trump Continues To Hype ItOn June 15, the FDA revoked its emergency use authorization for the drug, following numerous studies that illustrated no benefits of its use with hospitalized patients.
Read more »
Hydroxychloroquine doesn't help Covid-19 patients who aren't hospitalized, new study findsThe antimalarial drug hydroxychloroquine did not benefit non-hospitalized patients with mild symptoms from Covid-19 who were treated early in their infection, according to a new study
Read more »
Americans on COVID-19 jobless benefits spent more than when working, study showsAmericans who received enhanced unemployment benefits due to the coronavirus pandemic spent more than when they were working, a study released on Thursday said, adding to concerns about a steep fall in spending when the emergency benefits expire.
Read more »
1 in 3 Young Adults Are Vulnerable to Severe COVID-19, a New Study FindsA study found that 32 percent of young adults are at risk for severe COVID-19, with smoking as the biggest factor.
Read more »